Related Experiment Video
Updated: Mar 29, 2026
06:47
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
12.7K
Mechanisms for glyproline protection in hypercholesterolemia
Nikolay F Myasoedov1, Ludmila A Lyapina2, Marina E Grigorjeva2
1Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, Russia.
Summary
Small regulatory glyproline peptides, including Pro-Gly-Pro-Leu, show significant hypocholesterolemic and antithrombotic effects. These peptides improve lipid metabolism and enhance the anticoagulation system in rats with hypercholesterolemia.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Research
Background:
- Hypercholesterolemia is a major risk factor for thrombotic events.
- Small regulatory peptides are being investigated for therapeutic potential.
- Glyproline peptides, such as Pro-Gly-Pro, Arg-Pro-Gly-Pro, and Pro-Gly-Pro-Leu, are of interest due to their potential biological activities.
Purpose of the Study:
- To comparatively analyze the hypocholesterolemic and antithrombotic effects of specific glyproline peptides.
- To evaluate the impact of intranasal administration of these peptides on lipid metabolism and coagulation in an experimental model.
Main Methods:
- Experimental hypercholesterolemia model induced in rats fed a high-fat diet.
- Intranasal administration of glyproline peptides (Pro-Gly-Pro, Arg-Pro-Gly-Pro, Pro-Gly-Pro-Leu).
- Assessment of plasma lipid profiles, anticoagulant activity, fibrinolytic properties, and platelet aggregation.
Main Results:
- Intranasal glyproline peptide administration improved anticoagulation and fibrinolysis.
- Significant reduction in platelet aggregation was observed.
- Normalization of total cholesterol levels indicated a hypocholesterolemic effect.
- The peptide Pro-Gly-Pro-Leu demonstrated the most potent anticoagulant and hypocholesterolemic activity.
Conclusions:
- Glyproline peptides possess significant hypocholesterolemic and antithrombotic properties.
- Pro-Gly-Pro-Leu is a promising candidate for further investigation.
- Intranasal delivery is an effective route for administering these peptides to modulate lipid metabolism and thrombosis risk.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:29Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
3.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K
01:32Lipids as Anchors
8.0K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
8.0K
01:26Atherosclerosis III: Management
582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
01:05Proteoglycans
5.2K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.2K